A 64-year-old man with long-standing type 2 diabetes and hypertension is found to have an albumin:creatinine ratio (ACR) of 25 mg/mmol and an eGFR of 55 mL/min/1.73 m². He is not currently on an ACE inhibitor or ARB. According to current guidance, what is the most appropriate management regarding his renal risk?